Clinical features of psoriatic arthritis
Related Experiment Video
Updated: Oct 1, 2026

Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Abstract:
The past 5 years have seen major advances in understanding the immunology and molecular biology of psoriatic arthritis (PsA), especially the impact of cytokines such as tumor necrosis factor (TNF), which has produced striking, long-term benefits in patients with rheumatoid arthritis (RA). Because PsA is not the same disease as RA, the ability to distinguish between them is important to physicians in managing patients who have clinical features consistent with an arthropathy. The development of TNF inhibitors directed specifically at the mechanisms of skin and joint inflammation offers hope to patients who suffer from the debilitating effects of PsA.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Multiple Sclerosis l: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Peripheral Artery Disease I: Introduction